21 May 2019 : Clinical Research
Non-Medical Use of Prescription Stimulants for Treatment of Attention Disorders by University Students: Characteristics and Associations
Liat Korn1ABCDEF*, Kineret Hassan1CDEF, Nadya Fainshtein1CDEF, Nizmit Yusov1CDEF, Nitza Davidovitch2ACDEFGDOI: 10.12659/MSM.913973
Med Sci Monit 2019; 25:3778-3787
Abstract
BACKGROUND: Non-medical use of prescription stimulants (NPS) for treatment of attention deficit hyperactivity disorders (ADHD), which are considered narcotic substances and medical drugs, are used to treat learning and attention disorders. The purpose of this study was to investigate associations between misuse of medications for treatment of ADHD and various characteristics and problem behaviors, such as impulsivity, deviant behavior, and drug use.
MATERIAL AND METHODS: A total of 1280 undergraduate students (64% females; mean age 27; SD=6) completed an anonymous, structured, self-report questionnaire on health, well-being, and health risk behaviors.
RESULTS: NPS for treatment of ADHD was significantly associated with cannabis AOR (adjusted odds ratio)=5.57, P<0.001, compared to non-users. Deviant behaviors were significantly more prevalent among students engaging in medical use of prescription stimulants for treatment of ADHD (P=0.01; 43.2% and misuse 51.1%) versus non-users (34.5%).
CONCLUSIONS: Social attention in needed and implementing of social policy to raise students’ awareness of the problems involved in misuse of medications for treatment of ADHD, to form intervention programs tailored for students, and to refer students for appropriate counseling and diagnosis.
Keywords: Attention Deficit and Disruptive Behavior Disorders, Cannabis, Prescription Drug Misuse, Risk-Taking, Students, Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Impulsive Behavior, Israel, Marijuana Smoking, Methylphenidate, Prevalence, Substance-Related Disorders, Universities, young adult
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Database Analysis
Utility of Central Venous Oxygen Saturation Gradient in Predicting Mortality in Dialysis with Catheter AccessMed Sci Monit In Press; DOI: 10.12659/MSM.947298
Clinical Research
Intraoperative Renal Near-Infrared Spectroscopy Monitoring as a Predictor of Renal Outcomes in Cardiac SurgeryMed Sci Monit In Press; DOI: 10.12659/MSM.947462
Clinical Research
Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical CancerMed Sci Monit In Press; DOI: 10.12659/MSM.945964
Clinical Research
Inflammatory Biomarkers in Smokers: Implications for Ligamentum Flavum HypertrophyMed Sci Monit In Press; DOI: 10.12659/MSM.947508
Most Viewed Current Articles
17 Jan 2024 : Review article 7,148,090
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,355
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,723
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 21,937
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912